- Datum05.02.2025
- Uhrzeit15:00 - 16:00 Uhr
- Veranstalter
XTB
Jochen Schmidt
Moderator
Trinity Biotech PLC Reg.Shs A (Sp.ADRs New)/5 o.N. Aktie
Verkaufen
Kaufen
Trinity Biotech PLC Reg.Shs A (Sp.ADRs New)/5 o.N. Chart
Trinity Biotech PLC Reg.Shs A (Sp.ADRs New)/5 o.N. Realtime-Kurs
| Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| Nasdaq | VK | |||||
| Nasdaq Basic | VK | |||||
| Cboe BZX | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
0,54 %
Intraday
-29,55 %
1 Woche
-0,58 %
1 Monat
5,66 %
Seit Jahresbeginn
-69,44 %
1 Jahr
-84,10 %
3 Jahre
-83,39 %
5 Jahre
-99,02 %
10 Jahre
Wikifolio
Passender Service zu Trinity Biotech PLC Reg.Shs A (Sp.ADRs New)/5 o.N.
Webinar zu Trinity Biotech PLC Reg.Shs A (Sp.ADRs New)/5 o.N.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)0,740-3,550
- Jahrestief / Hoch ($)0,740-1,480
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Trinity Biotech PLC Reg.Shs A (Sp.ADRs New)/5 o.N.
| Ex-Datum | Fiskaljahr | Dividende | Rendite |
|---|---|---|---|
| 05.06.2015 | 2014 | 0,22 $ | 0,25 % |
| 06.06.2014 | 2013 | 0,22 $ | 0,19 % |
| 06.06.2013 | 2012 | 0,20 $ | 0,23 % |
| 06.06.2012 | 2011 | 0,15 $ | 0,27 % |
| 07.06.2011 | 2010 | 0,10 $ | 0,20 % |
Termine von Trinity Biotech PLC Reg.Shs A (Sp.ADRs New)/5 o.N.
Keine aktuellen Termine
Beschreibung
Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Rest of World - Ireland of which it derives a majority of its revenues from the Americas segment.
